About: AdAlta Limited, a clinical-stage biotechnology company, develops cellular immunotherapies for the treatment of solid cancers in Australia. The company also commercializes protein therapeutics. In addition, it engages in the development of AD-21, a protein therapeutic for fibrotic diseases, including lung fibrosis and kidney fibrosis in Phase 1 clinical studies; and WD-34, a discovery stage i-body for the treatment and prevention of malaria and related diseases. The company was incorporated in 2006 and is based in Hawthorn East, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.00 (-14.29%)
1AD ASX Adalta Ltd
Adalta Ltd share price
1AD price activity
Último preço
$ 0,000
Variação (24h)
-0,00 AUD (-14,29%)
Volume
147.31K
Volume (média 4 sem.)
-
Abertura
$ 0,00
Variação do dia
$ 0,00 - $ 0,00
Fechamento anterior
$ 0,00
Último negócio
06 Oct, 4:21 am GMT+0
Atrasado
06 Oct, 4:21 am GMT+0
1AD price performance
Atrasado
06 Oct, 4:21 am GMT+0
quote.marketSignals